Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,080 | -16,641 | -6,085 | -24,734 | -14,333 |
| Depreciation Amortization | 287 | 186 | 92 | 419 | 322 |
| Other Working Capital | 1,132 | 203 | -1,634 | 19,357 | 18,702 |
| Other Operating Activity | 2,617 | 1,321 | 487 | 7,448 | 2,818 |
| Operating Cash Flow | $-24,044 | $-14,931 | $-7,140 | $2,490 | $7,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -855 | -10 | -10 | -235 | -144 |
| Investing Cash Flow | $-855 | $-10 | $-10 | $-235 | $-144 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 19,451 |
| Debt Repayment | -4,683 | -4,683 | -700 | N/A | -2,100 |
| Common Stock Issued | 298,096 | 298,096 | 16 | N/A | 58 |
| Other Financing Activity | -21,826 | -20,480 | 2,007 | 89,233 | 0 |
| Financing Cash Flow | $271,587 | $272,933 | $1,323 | $89,233 | $17,409 |
| Beginning Cash Position | 94,578 | 94,578 | 94,578 | 3,090 | 3,090 |
| End Cash Position | 341,266 | 352,570 | 88,751 | 94,578 | 27,864 |
| Net Cash Flow | $246,688 | $257,992 | $-5,827 | $91,488 | $24,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,044 | -14,931 | -7,140 | 2,490 | 7,509 |
| Capital Expenditure | -855 | -10 | -10 | N/A | -144 |
| Free Cash Flow | -24,899 | -14,941 | -7,150 | 2,490 | 7,365 |